RESEARCH PAPER
Association between obesity and non-alcoholic fatty liver disease (NAFLD) in adults aged 18 years and above – data from NHANES 2017–2018
More details
Hide details
1
Department of Nutrition, Xingtai People’s Hospital, Xingtai, China
Corresponding author
Yao Yao
Nutrition, Xingtai People's Hospital, China
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Studies have Increasingly addressed a possible association between obesity and non-alcoholic fatty liver disease (NAFLD), although it remains an issue of controversy. The aim in the study is to determine an association between obesity and NAFLD among 1,120 adults ≥ 18 years of age, through a cross-sectional analysis of the National Health and Nutrition Examination Survey from 2017–2018.
Material and methods:
Data analyzed in the study were obtained from the NHANES database which provides multitudinous information concerning the health and nutrition of the general population in the USA. Data obtained from the NHANES surveys, conducted between 2017–2018, was utilised. A multivariable logistic regression model was used to determine the association between obesity and NAFLD.
Results:
Of the 1,120 participants enrolled, 434 (38.75%) had NAFLD. There was a positive association between obesity and NAFLD in all three models: model 1 – OR=1.80, 95% CI: 1.39–2.21; model 2 – OR=1.87, 95% CI: 1.41–2.33; model 3 – OR=1.76, 95% CI: 1.29–2.22). There was a positive association between BMI and NAFLD in all three models (model 1: OR=1.18, 95% CI: 1.13–1.23; model 2: OR=1.19, 95% CI: 1.14–1.25; model 3: OR=1.18, 95% CI: 1.12–1.24).
Conclusions:
The study findings confirm a strong association between obesity and NAFLD in individuals aged 18 and older, leading to a significantly elevated risk of NAFLD among those who are obese. Therefore, it is concluded that prompt interventions by healthcare professionals are necessary to facilitate weight reduction and support the recovery of health in obese patients.
FUNDING
Clinical application of perioperative nutritional support
in accelerated rehabilitation surgery for patients with liver
cirrhosis and portal hypertension (2019ZC254).
REFERENCES (34)
1.
Sasaran MO, Muntean C, Lupu A, Lupu VV. Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease. Front Cell Dev Biol. 2023;11:1336033.
2.
Saleh SAK, Santos HO, Gaman MA, et al. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2024;59:70–80.
3.
Chen Y, Gan Y, Zhong H, et al. Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease. Front Microbiol. 2023;14:1285473.
4.
Guo WP, Zhang HY, Liu LX. Risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2023;27(24):11890–11903.
5.
Raza S, Rajak S, Singh R, et al. Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease. World J Hepatol. 2023;15(12):1272–1283.
6.
Tse C, Lisanti N, Grubert Van Iderstine M, et al. Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective study. Can Liver J. 2023;6(4):395–406.
7.
Papadopoulos G, Legaki AI, Georgila K, et al. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity. Metabolism. 2023;144:155552.
8.
Gu W, Han T, Sun C. Association of 24 h Behavior Rhythm with Non-Alcoholic Fatty Liver Disease among American Adults with Overweight/Obesity. Nutrients. 2023;15(9).
9.
Czarnowski P, Wierzbicka-Rucinska A, Socha P. Relationship of gut microbiota and immunological response in obesity-related non-alcoholic fatty liver disease in children. Acta Biochim Pol. 2023;70(3):469–474.
10.
Asatullina Z, Sineglazova AV. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease. Cureus. 2023;15(8):e43711.
11.
Zhu Y, Yang H, Zhang Y, et al. Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity. Front Public Health. 2022;10:1038435.
12.
Chen N, Cao J, Zhang W, et al. Gender differences in the correlation between body mass index and cognitive impairment among the community-dwelling oldest-old in China: a cross-sectional study. BMJ Open. 2022;12(11):e065125.
13.
Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterol. 2019;156(5):1264–1281 e1264.
14.
Younossi ZM, Paik JM, Al Shabeeb R, et al. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022;76(5):1423–1437.
15.
Barr RG, Ferraioli G, Palmeri ML, et al. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiol. 2015;276(3):845–861.
16.
Siddiqui MS, Vuppalanchi R, Van Natta ML, et al. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019;17(1):156–163 e152.
17.
Paik JM, Deshpande R, Golabi P, et al. The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;51(2):291–304.
18.
Ng CH, Xiao J, Chew NWS, et al. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality. Front Med. (Lausanne) 2022;9:985803.
19.
Bowen PG, Lee LT, Martin MY, Clay OJ. Depression and physical functioning among older Americans with diabesity: NHANES 2009–2010. J Am Assoc Nurse Pract. 2017;29(2):70–76.
20.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
21.
Grinshpan LS, Eilat-Adar S, Ivancovsky-Wajcman D, et al. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review. JHEP Rep. 2024;6(1):100964.
22.
Sahu P, Chhabra P, Mehendale AM. A Comprehensive Review on Non-Alcoholic Fatty Liver Disease. Cureus. 2023;15(12):e50159.
23.
Peloso A, Lacotte S, Gex Q, et al. Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models. PLoS One 2023;18(12):e0296265.
24.
Misan IA, Arisheva OS, Garmash IV, et al. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure. Kardiologia. 2023;63(12):72–76.
25.
Pirola CJ, Sookoian S. Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension. Liver Int. 2023;43(10):2167–2176.
26.
Soltanieh S, Salavatizadeh M, Poustchi H, et al. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM). Heliyon. 2023;9(3):e13983.
27.
Wang Y, Yuan T, Deng S, et al. Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population. Front Nutr. 2023;10:1104859.
28.
Zhao D, Cui H, Shao Z, Cao L. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol. 2023;28(4):100726.
29.
Aboujassoum HM, Mohamed-Ali V, Abraham D, et al. Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats. Nutrients. 2023;16(1).
30.
Li X, Chen W, Ren J, et al. Effects of curcumin on non-alcoholic fatty liver disease: A scientific metrogy study. Phytomedicine. 2024;123:155241.
31.
Zhao T, Lun S, Yan M, et al. 6,7-Dimethoxycoumarin, Gardenoside and Rhein combination improves non-alcoholic fatty liver disease in rats. J Ethnopharmacol. 2024;322:117646.
32.
De Herdt C, De Block C, Francque S, et al. A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesity. Endocrine. 2023;80(1):54–63.
33.
Likitnukul S, Tepaarmorndech S, Kaewamatawong T, et al. Pyridylnidulin exerts anti-diabetic properties and improves non-alcoholic fatty liver disease in diet-induced obesity mice. Front Mol Biosci. 2023;10:1208215.
34.
Aljabri D. Associations Between Obesity, Physical Inactivity, Healthcare Capacity, and the Built Environment: Geographic Information System Analysis. J Multidiscip Healthc. 2022;15:689–704.